[Asia Economy Reporter Yoo Hyun-seok] NextEye announced on the 10th that the payment for the 5th series convertible bonds (CB) worth 5 billion KRW has been completed. Along with the 8.6 billion KRW 4th series convertible bonds paid on the 4th, a total of 13.6 billion KRW in funding has been secured.
NextEye plans to accelerate its entry into new bio businesses by utilizing the raised funds and the company's internal reserves. Last month, NextEye secured a large amount of funds by receiving approximately 63.4 billion KRW from the sale of its subsidiary Inometry.
A NextEye official stated, "Through the sale of Inometry and the issuance of CBs, we have secured about 77 billion KRW in total funds," adding, "We will significantly improve our financial structure to establish a sound financial foundation and secure future growth engines by promoting new businesses centered on bio sectors such as fillers."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
